ReviewNeurology2023
Variation in Endpoints in FDA Medication Approvals: A Review of Acute and Preventive Migraine Medications.
Leigh K Sharpless et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it